about
Molecular identification of black-grain mycetoma agentsNovel Taxa Associated with Human Fungal Black-Grain Mycetomas: Emarellia grisea gen. nov., sp. nov., and Emarellia paragrisea sp. novEstimating the burden of mucormycosis infections in France (2005-2007) through a capture-recapture method on laboratory and administrative data.Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection SGeosmithia argillacea: an emerging pathogen in patients with cystic fibrosis.Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosisIn vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.Molecular identification of zygomycetes from culture and experimentally infected tissues.In vitro combination of voriconazole and miltefosine against clinically relevant molds.Acquired resistance to echinocandins in Candida albicans: case report and review.Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of MucoralesCombination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans.Carbon assimilation profiles as a tool for identification of zygomycetesCandida spp. with acquired echinocandin resistance, France, 2004-2010.In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates.Detection of caspofungin resistance in Candida spp. by Etest.Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin.Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.Activity of posaconazole in treatment of experimental disseminated zygomycosis.Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion MethodMolecular tools for identification of Zygomycetes and the diagnosis of zygomycosis.Healthcare-associated mucormycosis.Molecular identification of fungi found on decomposed human bodies in forensic autopsy cases.Fatal Pulmonary Mucormycosis due to Rhizopus homothallicus.In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris.Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single-center 15-year experience.Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor.A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species.Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients.Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France.Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles.Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin.ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.
P50
Q24669636-5543A113-2F40-4CCF-90E5-820CC1C9184EQ28828827-AFED4702-79DB-46E8-9059-BAB378E45DB5Q30571217-B0646D49-3B49-42B2-9C9C-BEBFE29D3E62Q33909379-DE399344-8CC7-428D-AA9A-F9C9945BEC05Q33963545-7BD93BE2-CAFB-4E6C-8AD9-789B3EFC2BAAQ34109399-003E0BB1-2C24-4432-88DD-FD53E151E993Q34110440-F856A2D3-011C-4598-A383-815957EAC4AAQ34143259-3620AD05-870F-4F5E-A7BF-9448520B7505Q34301547-7D44707B-7CFA-4CE3-91DD-A220D69BCE63Q34430706-DE08AAAE-C4FC-4528-9814-7274C20D9473Q34596890-4AAB2BE8-F747-480B-8267-4D755D423AD2Q34623936-3D1F8931-20E2-48A8-A6D1-CF0B734F47A1Q35076896-788DA703-AC61-49B8-A432-F1813858D47DQ35635773-12306AB4-2F49-48A3-A3A6-E56D14EC1D26Q35784447-26620DD0-CAB9-4DF9-9A87-8429ADBE872CQ35845865-64847666-1ECC-45E8-BF25-7B770928D7A1Q36047748-16B74A6D-1A69-4B18-BE9B-3810A9B31871Q36747567-32E14E45-8E95-46CD-8B82-0202F1777999Q36785949-0AB1F325-56CE-4E5D-9872-8AA9B549B49AQ36870777-D12CC40E-D087-4D82-A742-776FBC72671FQ36880761-090262A7-7FD6-4B1C-ADD0-1D8DAB722F7FQ37156876-C561AC1D-13C9-4B9C-A617-61719D617C24Q37274705-FF6C0849-D14E-417A-AE32-BA775C006661Q37335747-11EBD379-48EF-4552-99AF-4F020C5B42AEQ37538775-D32F8EB3-060C-4337-B719-8966E4C76480Q37597557-03CB30D8-ACE7-44E7-8DA8-430387F9C47AQ37976049-90246A49-0626-4340-9B59-89426755DC1AQ38268339-04D93A1C-75CA-4242-81D8-24CDBD1C6654Q38744413-6F68362D-A61E-4755-905A-1819B5E3713EQ39092177-78BE8832-296C-4877-BD94-CF81B3EBE24BQ39375883-89363D46-2B27-45A2-95B7-057BF07F48DAQ39742832-2319DC45-43D2-462B-AA99-970A6AAB3192Q40016281-EAFBE7C4-3115-4ECA-BBF3-31B4F325F0CDQ40034825-592DE4FE-8385-467A-A40E-046E4F6DA691Q40448192-B770FBC9-0F0F-4A96-951B-9DCC61C3AF4FQ40887693-A3E8A224-7323-4923-8FC5-2958870C7DB8Q41199783-5B949334-BDB8-4605-8DFC-50067899024EQ41542809-9D95993C-9FC3-4F7F-966B-3567A3549696Q42092940-590680E2-0F24-4BDA-AE47-42201D698D4FQ42227953-3291FD60-B48F-4CE5-8BCE-430874252D3A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eric Dannaoui
@ast
Eric Dannaoui
@en
Eric Dannaoui
@es
Eric Dannaoui
@nl
type
label
Eric Dannaoui
@ast
Eric Dannaoui
@en
Eric Dannaoui
@es
Eric Dannaoui
@nl
prefLabel
Eric Dannaoui
@ast
Eric Dannaoui
@en
Eric Dannaoui
@es
Eric Dannaoui
@nl
P106
P1153
7004264766
P31
P496
0000-0002-2817-3830